IL-2/gd T cell

Molecular group: 
Cytokines and receptors
Molecule/Cell: 
IL-2/gd T cell
Plasmodium strain: 
Plasmodium yoelii 17XL
pRBC infection titer: 
5 x 10^5
Mouse genetic background (Con): 
DBA/2
Experimental treatment group (EG): 
rIL-2 + anti -gd-T cell
Lethal infection (Con): 
no
Lethal infection (EG): 
71%
Pathology (Con): 
None
Pathology (EG): 
CM (71%)
Parasitemia (EG vs Con): 
Similar
Additional phenotypes (EG vs Con): 
Anti-gd treatment delayed (2-3 weeks) or abrogated (2/7 mice stayed healthy until the last day of observation) cerebral symptoms compared to rIL-2 treatment alone
Refs: 
Haque et al., 2001, Am J Pathol